MOREPENLAB NSE filing

Morepen Labs Reports Status on Physical Share Transfer Requests Under SEBI Special Window

The RealCase readLow impact Neutral

Morepen Laboratories Limited received a report on physical share transfer requests under SEBI's special window (Jan 1-6, 2026). As of Jan 1, 2026, no requests were received, processed, approved, or rejected during this period.

Why it matters

This is a procedural update concerning share transfers and does not have a material financial or strategic impact on the company.

The market read

The announcement is a routine update regarding the processing of physical share transfer requests and does not contain any positive or negative financial or operational news.

Morepen Laboratories Limited has provided an update regarding the re-lodgement of physical share transfer requests. The company received a status report dated January 28, 2026, from its Registrar and Share Transfer Agent, MAS Services Limited. This report pertains to the special six-month window granted by SEBI for such re-lodgements, which ran from January 1, 2026, to January 6, 2026.

According to the information provided by MAS Services Limited as of January 1, 2026, there were no requests received, processed, approved, or rejected during the specified period for the re-lodgement of physical share transfer requests. The average processing time for requests was also not applicable as no requests were processed.

This update is in compliance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025, which provided a special window for shareholders to re-lodge transfer requests for physical shares.

Filing to action

What to do with a filing like this

Morepen Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Morepen Laboratories Limited. Read the original for the full detail.

View original filing